EU Court says yes to Anheuser-Busch’s Bud CTM

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EU Court says yes to Anheuser-Busch’s Bud CTM

Businesses that want to oppose Community trade marks have been given more guidance from the CJEU’s General Court as to how it will apply the rules on the use of a sign “in the course of trade of more than mere local significance”

In the latest round of a long-running legal battle between rival brewers Anheuser-Busch and Budějovický Budvar,the Court ruled yesterday that the Czech company could not prevent the registration of the Community trade mark Bud for beer.

Budějovický Budvar had opposed Anheuser-Busch’s application to OHIM, citing the existence of the appellation of origin “bud”, as protected in France, Italy and Portugal under the Lisbon Agreement and in Austria under bilateral deals between Austria and the former Czechoslovak Socialist Republic.

OHIM dismissed Budějovický Budvar’s oppositions on the grounds that its evidence of the use of the appellation of origin “bud” in Austria, France, Italy and Portugal was insufficient.

OHIM’s decision was ultimately appealed to the Court of Justice, which held that a geographical indication protected in a member state can only prevent the registration of a CTM if it was actually used in a sufficiently significant manner in the course of trade in a substantial part of the territory of that state.

The General Court was asked to consider whether that criterion had been met in this case.

On January 22 the Court ruled that it had not.

In particular, it said that the Czech company had not shown OHIM evidence of the use of the term bud in the course of trade of more than mere local significance before the US company filed its CTM application in July 1996.

Budějovický Budvar produced invoices showing deliveries using the term bud to just three towns in France. As such, the Court said it had not satisfied the “more than mere local significance” test. Its sales of beer using the bud name were similarly low in Austria.

more from across site and SHARED ros bottom lb

More from across our site

An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
With the London Annual Meeting behind us, we look back at some of the lessons learned this week and ahead to what 2027 will bring
Gift this article